Embecta Corp. (EMBC)
Nasdaq: EMBC · Surgical & Medical Instruments & Apparatus · Wilmington, DE · filing with the SEC since 2021
Income statement, as filed
In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in September.| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Period ending | Sep 30, 2025 | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 |
| Report filed | Nov 25, 2025 | Dec 11, 2024 | Nov 29, 2023 | Dec 22, 2022 | · | · |
| Revenue | 1,080.4 | 1,123.1 | 1,120.8 | 1,129.5 | 1,165.3 | 1,085.5 |
| Cost of revenue | 403.6 | 387.9 | 370.9 | 354.6 | 364.9 | 322.9 |
| Gross profit | 676.8 | 735.2 | 749.9 | 774.9 | 800.4 | 762.6 |
| Research and development | 37.3 | 78.8 | 85.2 | 66.9 | 63.3 | 61.4 |
| Selling, general and administrative | 332.0 | 365.1 | 341.3 | 294.8 | 240.3 | 214.7 |
| Total operating expenses | 434.7 | 568.4 | 528.4 | 465.3 | 308.4 | 276.1 |
| Operating income | 242.1 | 166.8 | 221.5 | 309.6 | 492.0 | 486.5 |
| Interest and investment income | 6.0 | 12.0 | 9.4 | 0.0 | 0.0 | · |
| Interest income (expense), net | -107.3 | -112.3 | -107.0 | -46.2 | 0.0 | 0.0 |
| Total non-operating income (expense) | 1.5 | -10.3 | -8.8 | -6.8 | 2.9 | -0.7 |
| Income before income taxes | 136.3 | 44.2 | 105.7 | 256.6 | 494.9 | 485.8 |
| Income tax expense | 40.9 | -34.1 | 35.3 | 33.0 | 80.1 | 58.2 |
| Net income | 95.4 | 78.3 | 70.4 | 223.6 | 414.8 | 427.6 |
| Earnings per share, basic | 1.64 | 1.36 | 1.23 | 3.92 | 7.28 | 7.50 |
| Earnings per share, diluted | 1.62 | 1.34 | 1.22 | 3.89 | 7.28 | 7.50 |
| Weighted average shares, basic | 58,309 | 57,681 | 57,248 | 57,024 | 57,013 | 57,013 |
| Weighted average shares, diluted | 58,915 | 58,326 | 57,758 | 57,461 | 57,013 | 57,013 |
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it sold
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTaxCost of revenue what it cost to make or buy what it sold
us-gaap:CostOfGoodsAndServicesSoldGross profit revenue less the cost of what it sold
us-gaap:GrossProfitResearch and development spent on inventing what it sells next
us-gaap:ResearchAndDevelopmentExpenseSelling, general and administrative the cost of selling and of running the company
us-gaap:SellingGeneralAndAdministrativeExpenseTotal operating expenses the running costs together
us-gaap:OperatingExpensesOperating income profit from running the business, before interest and tax
us-gaap:OperatingIncomeLossInterest and investment income what its cash and investments earned
us-gaap:InterestIncomeOtherInterest income (expense), net interest earned less interest paid, outside the business
us-gaap:InterestIncomeExpenseNonoperatingNetTotal non-operating income (expense) everything outside the business, together
us-gaap:NonoperatingIncomeExpenseIncome before income taxes profit before tax
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncome tax expense tax charged on the period's profit
us-gaap:IncomeTaxExpenseBenefitNet income the profit or loss that belongs to the company's shareholders
us-gaap:NetIncomeLossEarnings per share, basic net income per share outstanding
us-gaap:EarningsPerShareBasicEarnings per share, diluted net income per share, counting every share that could be issued
us-gaap:EarningsPerShareDilutedWeighted average shares, basic the average count of shares outstanding
us-gaap:WeightedAverageNumberOfSharesOutstandingBasicWeighted average shares, diluted the average count with every share that could be issued
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding